Answers are grounded in this paper and cite their sources.
CD4 + T cells play fundamental roles in orchestrating immune responses and tissue homeostasis. However, our inability to associate peptide human leukocyte antigen class-II (HLA-II) complexes with their cognate T cell receptors (TCRs) in an unbiased manner has hampered our understanding of CD4 + T cell function and role in pathologies. Here, we introduce TScan-II, a highly sensitive genome-scale CD4 + antigen discovery platform. This platform seamlessly integrates the endogenous HLA-II antigen-processing machinery in synthetic antigen-presenting cells and TCR signaling in T cells, enabling the simultaneous screening of multiple HLAs and TCRs. Leveraging genome-scale human, virome, and epitope mutagenesis libraries, TScan-II facilitates de novo antigen discovery and deep exploration of TCR specificity. We demonstrate TScan-II's potential for basic and translational research by identifying a non-canonical antigen for a cancer-reactive CD4 + T cell clone. Additionally, we identified two antigens for clonally expanded CD4 + T cells in Sjögren's disease, which bind distinct HLAs and are expressed in HLA-II-positive ductal cells within affected salivary glands.
No takes yet. Share an insight, caveat, or question.
Dezfulian et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: